Dry Eye Syndrome Description During Cataract Surgery, With Multimodal Analysis of the Ocular Surface
Launched by UNIVERSITY HOSPITAL, CLERMONT-FERRAND · Apr 19, 2019
Trial Information
Current as of April 26, 2025
Completed
Keywords
ClinConnect Summary
Type of study: Descriptive study, interventional research involving the human person at risk and with minimal constraints (type 2), prospective, with longitudinal cohort follow-up, mono-centric.
Number of centres: 1; The protocol will take place in the ophthalmology department of the Clermont-Ferrand University Hospital.
Study description: The study will follow the normal protocol for cataract surgery. Patients will not have any additional consultation to perform this study. The classic consultation scheme involves a preoperative appointment to set the surgical indication and inform patie...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients (≥ 18 years old)
- • consultants to benefit from a scheduled cataract operation at Clermont Ferrand University Hospital
- • affiliation to a social security scheme
- • ability to give informed consent to participate in the study.
- Exclusion Criteria:
- • - Patient without cataract surgery
- • Congenital cataract
- • Refusal to participate in the study
- • Inability to answer the questionnaire (cognitive impairment, comprehension difficulties...)
- • Eyelid abnormalities that may cause palpebral unocclusion
- • Patient under judicial protection (guardianship, curatorship, measure to safeguard justice) or deprived of liberty
- • inability to recheck the patient
About University Hospital, Clermont Ferrand
The University Hospital of Clermont-Ferrand is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its multidisciplinary approach, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes collaboration among healthcare professionals, researchers, and academic partners. With a strong commitment to improving patient outcomes, the institution actively engages in a wide array of clinical studies, ranging from early-phase trials to large-scale interventions, aimed at addressing critical health challenges and enhancing treatment modalities. Its state-of-the-art facilities and expertise make it a pivotal contributor to clinical research in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Clermont Ferrand, , France
Patients applied
Trial Officials
frédéric Chiambaretta
Principal Investigator
University Hospital, Clermont-Ferrand
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials